Price T Rowe Associates Inc Soma Logic, Inc. Transaction History

Price T Rowe Associates Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$1.76 - $2.83 $14,725 - $23,678	-8,367 Reduced 10.08%	74,599 $189,000
Q3 2023 Nov 14, 2023	BUY	$1.99 - $2.45 $7,325 - $9,018	3,681 Added 4.64%	82,966 $199,000
Q2 2023 Aug 14, 2023	BUY	$2.1 - $3.36 $2,860 - $4,576	1,362 Added 1.75%	79,285 $184,000
Q1 2023 May 15, 2023	BUY	$2.13 - $3.6 $8,055 - $13,615	3,782 Added 5.1%	77,923 $199,000
Q4 2022 Feb 14, 2023	BUY	$2.05 - $3.47 $29,185 - $49,402	14,237 Added 23.77%	74,141 $186,000
Q3 2022 Nov 14, 2022	SELL	$0.63 - $5.47 $2.65 Million - $23 Million	-4,209,521 Reduced 98.6%	59,904 $174,000
Q2 2022 Aug 15, 2022	SELL	$4.27 - $8.26 $6.69 Million - $12.9 Million	-1,567,589 Reduced 26.86%	4,269,425 $19.3 Million
Q1 2022 May 16, 2022	BUY	$7.07 - $11.62 $7.91 Million - $13 Million	1,118,293 Added 23.7%	5,837,014 $46.8 Million
Q4 2021 Feb 14, 2022	BUY	$10.49 - $14.28 $30.5 Million - $41.5 Million	2,903,722 Added 159.98%	4,718,721 $54.9 Million
Q3 2021 Nov 15, 2021	BUY	$9.94 - $12.77 $18 Million - $23.2 Million	1,814,999 New	1,814,999 $22.5 Million

7.48M

Ticker SLGC
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 183,452,992
Description
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.